NEXT Oncology is offering hope to cancer patients by treating the first patient in Texas with a new cellular immunotherapy. This is the first treatment of its kind at NEXT Oncology and the first clinical study offering the treatment to patients with solid tumors.
NEXT Oncology, founded by internationally known cancer researcher Dr. Anthony Tolcher, has entered into an agreement with the Quirónsalud Group to open two new phase I clinical trial centers in Spain. The venture increases global access to new agents and anticancer therapies for cancer patients. View the full article at Let Life Happen
A local oncologist talks about a group that’s at higher risk of dying from breast cancer. View the video at KSAT.com
Sharon Wilks joined NEXT Oncology’s phase I clinical investigation team, bringing more than 30 years of research and clinical experience to the practice. View the full article at the Cancer Letter
Wilks to focus on advancements in novel therapies for breast cancer (SAN ANTONIO) December 8, 2021 –– Medical oncologist Dr. Sharon Wilks joins NEXT Oncology bringing more than 30 years of research and clinical experience to the practice. NEXT Oncology’s Phase I oncology centers provide patients with advanced cancer access to the newest treatments available. Dr. Wilks focuses on research …
NEXT Oncology entered into an agreement with the Quirónsalud Group to open two new phase I clinical trial centers in Spain. View the full article at Cancer Letter
New venture marks third and fourth site expansion in five months (SAN ANTONIO) November 18, 2021 –– NEXT Oncology, founded by internationally known cancer researcher Dr. Anthony Tolcher, has entered into an agreement with the Quirónsalud Group to open two new phase I clinical trial centers in Spain. The venture increases global access to new agents and anticancer therapies for …
El Grupo Quirónsalud ha puesto en marcha dos nuevas unidades de ensayos clínicos de fase I gracias al acuerdo alcanzado con NEXT Oncology, empresa estadounidense líder en el desarrollo de este tipo de ensayos creará en Europa. The Quirónsalud Group has launched two new phase I clinical trial units thanks to the agreement reached with NEXT Oncology, a leading American company in the development of …
For the latest installment of the Inside the Practice Segment of the Medical World News® broadcast, CancerNetwork® spoke with Anthony W. Tolcher, MD, co-founder of NEXT Oncology and a medical oncologist at Texas Oncology, as well as Alexander I. Spira, MD, PhD, director of Virginia Cancer Specialists Research Institute and the Phase I Trial Program, to discuss their new partnership and how …
For the latest installment of the Inside the Practice Segment of the Medical World News® broadcast, CancerNetwork® spoke with Anthony W. Tolcher, MD, co-founder of NEXT Oncology and a mMedical oOncologist at Texas Oncology, as well as Alexander I. Spira, MD, PhD, Medical Oncologist and dDirector of Virginia Cancer Specialists Research Institute and the Phase I Trial Program, to discuss their new …
